Skip to content

Danaher DHR Diagnostics — Goodwill

Other segment segments

Biotechnology
$22.73B-1.8%
Life Sciences
$12.78B

Similar metrics at other companies

Opko Health logo
OPKDiagnostics — Goodwill
$163.44M0.0%
Revvity logo
RVTYDiagnostics — Goodwill
$1.86B-4.0%
Labcorp Holdings logo
LHDiagnostics — Goodwill
$5.61B
Revvity logo
RVTYDiagnostics — Goodwill, Acquisition
$0
Labcorp Holdings logo
LHDiagnostics — Goodwill acquired, excluding measurement period adjustments
$146.6M
Bio-Rad Laboratories logo
BIOClinical Diagnostics — Goodwill, net
$128.4M+4.3%

Other financials

Income statement

See full
Revenue$6.3B+5.5%
Gross profit$3.6B+2.5%
Operating income$1.1B+48.3%
Net income$870.0M+56.8%
EPS (diluted)$1.23+59.7%

Balance sheet

See full
Cash & equivalents$4.3B+47.0%
Total debt$27.9B+50.1%
Total equity$52.6B+0.5%
Total assets$92.4B+13.2%

Cash flow

See full
Operating cash flow$1.5B+14.6%
CapEx$269.0M+8.5%
Free cash flow$1.3B+16.1%

Valuation

See full
Market cap$134.62B-7.4%
Enterprise value$158.13B-1.7%
P/E33.6×-9.0×
P/S5.4×-0.7×

Profitability

See full
Gross margin58.5%-1.1pp
Operating margin20.4%+2.0pp
Net margin15.9%+1.7pp
FCF margin21.8%+1.5pp

Returns & leverage

See full
Return on equity7.6%+1.0pp
Debt / equity0.5×+0.2×
Current ratio1.7×0.0×

Where this comes from

Reported directly by Danaher in its filing.

Tagged under the XBRL concept us-gaap:Goodwill.

The official record: Danaher’s 10-Q, filed July 21, 2026, on SEC EDGAR. View the filing →

Ask your AI about Danaher's diagnostics — goodwill.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Danaher's diagnostics — goodwill?
Danaher (DHR) reported diagnostics — goodwill of $11.91B in Q2 2026.
How has Danaher's diagnostics — goodwill changed year-over-year?
Danaher's diagnostics — goodwill increased by 70.8% year-over-year, from $6.97B to $11.91B.
What is the long-term trend for Danaher's diagnostics — goodwill?
Over 4 years (2021 to 2025), Danaher's diagnostics — goodwill has grown at a -0.3% compound annual growth rate (CAGR), from $28.06B to $27.76B.
What does diagnostics — goodwill mean?
The premium paid over the fair value of net assets during the acquisition of businesses within the diagnostics segment. It represents intangible benefits such as brand reputation, customer loyalty, and synergies. This balance is subject to periodic impairment testing to ensure it remains supported by the segment's earnings power.